Uncommon Therapeutics
San Francisco
About Uncommon Therapeutics
Uncommon Therapeutics focuses on building drugs for rare diseases using cutting-edge technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $500.0K
- Funding stage: Seed
- Last round: Pre-Seed (Mar 2025)
- Website: uncommontherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/uncommon-therapeutics-46191 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.